The global market for Recombinant DNA Technology is estimated at US$68.3 Billion in 2023 and is projected to reach US$93.7 Billion by 2030, growing at a CAGR of 4.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. ![Recombinant DNA Technology Market]( "Recombinant DNA Technology Market")
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Medical Recombinant DNA Technology segment, which is expected to reach US$70.4 Billion by 2030 with a CAGR of 5.1%. The Non-Medical Recombinant DNA Technology segment is also set to grow at 3.3% CAGR over the next 7 years.
- Regional Analysis: Gain insights into the U.S. market, estimated at $20.2 Billion in 2023, and China, forecasted to grow at an impressive 4.3% CAGR to reach $16.5 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Recombinant DNA Technology Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Recombinant DNA Technology Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Recombinant DNA Technology Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Amgen Inc, Bamboo Therapeutics, Inc., Biocon, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 32 Featured):
- Amgen Inc
- Bamboo Therapeutics, Inc.
- Biocon
- Biogen
- Chiron Corporation
- Cibus
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd
- Genentech, Inc
- GenScript
- GlaxoSmithKline plc.
- Horizon Discovery Group plc
- Merck KGaA
- Monsanto Company
- New England Biolabs
- Novartis AG
- Novo Nordisk A/S
- Nucelis
- Pfizer Inc.
- Profacgen
- Sanofi
- Syngene
MarketGlass Platform
Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Global Economic Update
- Recombinant DNA Technology - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recombinant DNA Technology Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
- Table 2: World Recent Past, Current & Future Analysis for Recombinant DNA Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 3: World Historic Review for Recombinant DNA Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 4: World 16-Year Perspective for Recombinant DNA Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
- Table 5: World Recent Past, Current & Future Analysis for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 6: World Historic Review for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 7: World 16-Year Perspective for Medical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 8: World Recent Past, Current & Future Analysis for Non-Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 9: World Historic Review for Non-Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 10: World 16-Year Perspective for Non-Medical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 11: World Recent Past, Current & Future Analysis for Expression System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 12: World Historic Review for Expression System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 13: World 16-Year Perspective for Expression System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 14: World Recent Past, Current & Future Analysis for Cloning Vector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 15: World Historic Review for Cloning Vector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 16: World 16-Year Perspective for Cloning Vector by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 17: World Recent Past, Current & Future Analysis for Health & Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 18: World Historic Review for Health & Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 19: World 16-Year Perspective for Health & Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 20: World Recent Past, Current & Future Analysis for Food & Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 21: World Historic Review for Food & Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 22: World 16-Year Perspective for Food & Agriculture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 23: World Recent Past, Current & Future Analysis for Environmental by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 24: World Historic Review for Environmental by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 25: World 16-Year Perspective for Environmental by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 26: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 27: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 28: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
UNITED STATES
- Recombinant DNA Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- Table 29: USA Recent Past, Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 30: USA Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 31: USA 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2024 & 2030
- Table 32: USA Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 33: USA Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 34: USA 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2024 & 2030
- Table 35: USA Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 36: USA Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 37: USA 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2024 & 2030
CANADA
- Table 38: Canada Recent Past, Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 39: Canada Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 40: Canada 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2024 & 2030
- Table 41: Canada Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 42: Canada Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 43: Canada 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2024 & 2030
- Table 44: Canada Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 45: Canada Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 46: Canada 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2024 & 2030
JAPAN
- Recombinant DNA Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- Table 47: Japan Recent Past, Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 48: Japan Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 49: Japan 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2024 & 2030
- Table 50: Japan Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 51: Japan Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 52: Japan 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2024 & 2030
- Table 53: Japan Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 54: Japan Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 55: Japan 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2024 & 2030
CHINA
- Recombinant DNA Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- Table 56: China Recent Past, Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 57: China Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 58: China 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2024 & 2030
- Table 59: China Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 60: China Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 61: China 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2024 & 2030
- Table 62: China Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 63: China Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 64: China 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2024 & 2030
EUROPE
- Recombinant DNA Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- Table 65: Europe Recent Past, Current & Future Analysis for Recombinant DNA Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 66: Europe Historic Review for Recombinant DNA Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 67: Europe 16-Year Perspective for Recombinant DNA Technology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
- Table 68: Europe Recent Past, Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 69: Europe Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 70: Europe 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2024 & 2030
- Table 71: Europe Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 72: Europe Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 73: Europe 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2024 & 2030
- Table 74: Europe Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 75: Europe Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 76: Europe 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2024 & 2030
FRANCE
- Recombinant DNA Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- Table 77: France Recent Past, Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 78: France Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 79: France 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2024 & 2030
- Table 80: France Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 81: France Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 82: France 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2024 & 2030
- Table 83: France Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 84: France Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 85: France 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2024 & 2030
GERMANY
- Recombinant DNA Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- Table 86: Germany Recent Past, Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 87: Germany Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 88: Germany 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2024 & 2030
- Table 89: Germany Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 90: Germany Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 91: Germany 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2024 & 2030
- Table 92: Germany Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 93: Germany Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 94: Germany 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2024 & 2030
ITALY
- Table 95: Italy Recent Past, Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 96: Italy Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 97: Italy 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2024 & 2030
- Table 98: Italy Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 99: Italy Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 100: Italy 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2024 & 2030
- Table 101: Italy Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 102: Italy Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 103: Italy 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Recombinant DNA Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- Table 104: UK Recent Past, Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 105: UK Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 106: UK 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2024 & 2030
- Table 107: UK Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 108: UK Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 109: UK 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2024 & 2030
- Table 110: UK Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 111: UK Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 112: UK 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2024 & 2030
REST OF EUROPE
- Table 113: Rest of Europe Recent Past, Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 114: Rest of Europe Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 115: Rest of Europe 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2024 & 2030
- Table 116: Rest of Europe Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 117: Rest of Europe Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 118: Rest of Europe 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2024 & 2030
- Table 119: Rest of Europe Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 120: Rest of Europe Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 121: Rest of Europe 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Recombinant DNA Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- Table 122: Asia-Pacific Recent Past, Current & Future Analysis for Recombinant DNA Technology by Product Type - Medical and Non-Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 123: Asia-Pacific Historic Review for Recombinant DNA Technology by Product Type - Medical and Non-Medical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 124: Asia-Pacific 16-Year Perspective for Recombinant DNA Technology by Product Type - Percentage Breakdown of Value Sales for Medical and Non-Medical for the Years 2014, 2024 & 2030
- Table 125: Asia-Pacific Recent Past, Current & Future Analysis for Recombinant DNA Technology by Type - Expression System and Cloning Vector - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 126: Asia-Pacific Historic Review for Recombinant DNA Technology by Type - Expression System and Cloning Vector Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 127: Asia-Pacific 16-Year Perspective for Recombinant DNA Technology by Type - Percentage Breakdown of Value Sales for Expression System and Cloning Vector for the Years 2014, 2024 & 2030
- Table 128: Asia-Pacific Recent Past, Current & Future Analysis for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 129: Asia-Pacific Historic Review for Recombinant DNA Technology by Application - Health & Disease, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 130: Asia-Pacific 16-Year Perspective for Recombinant DNA Technology by Application - Percentage Breakdown of Value Sales for Health & Disease, Food & Agriculture, Environmental and Other Applications for the Years 2014, 2024 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Amgen Inc
- Bamboo Therapeutics, Inc.
- Biocon
- Biogen
- Chiron Corporation
- Cibus
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd
- Genentech, Inc
- GenScript
- GlaxoSmithKline plc.
- Horizon Discovery Group plc
- Merck KGaA
- Monsanto Company
- New England Biolabs
- Novartis AG
- Novo Nordisk A/S
- Nucelis
- Pfizer Inc.
- Profacgen
- Sanofi
- Syngene
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 88 |
| Published | May 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 68.3 Billion |
| Forecasted Market Value ( USD | $ 93.7 Billion |
| Compound Annual Growth Rate | 4.6% |
| Regions Covered | Global |
